| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 20 Jan 2025 | 12 Feb 2025 |
| Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 12, 2025 Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 12, 2025 (As Per NSE Announcement Dated on: 12.02.2025) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 12, 2025 (As Per NSE Announcement Dated on: 13.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.